KNBIF.US Kane Biotech Inc

Healthcare Biotechnology USA Stocks
0.0234 USD
Close of Nov 14, 2026
0.0104 0.0338
Market cap
USD 4.80M
P/E
-
P/B
102.61x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is KNBIF.US undervalued?

Graham number

The Graham number of Kane Biotech Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Kane Biotech Inc fundamental analysis

No fundamental analysis for Kane Biotech Inc yet.

Kane Biotech Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Kane Biotech Inc

Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, a biofilm destabilizing formula with continuous activity; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine (PNAG) for trea…

Full company profile